Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
197 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07171970 | IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women(SAIGON-PTC) | recruiting | N/A | 600 | Mỹ Đức HospitalOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06087120 | Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment(BRAVA) | recruiting | — | 125 | Gene SolutionsINDUSTRY | 2 | Sep 23, 2025 |
| NCT06131424 | NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients(iRetroBC) | completed | — | 1,151 | AstraZenecaINDUSTRY | 13 | Sep 18, 2025 | clinicaltrials |
| NCT06768463 | Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer(CYGAS-GC) | recruiting | N/A | 250 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06027957 | CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia | completed | Phase 1 | 18 | Vinmec Research Institute of Stem Cell and Gene TechnologyOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT07126626 | Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer | not yet recruiting | — | 1,184 | Gene SolutionsINDUSTRY | 1 | Aug 17, 2025 | clinicaltrials |
| NCT05029869 | Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description | active not recruiting | — | 100 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT06167460 | Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. | recruiting | — | 50 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06391749 | Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)(K-ACCELERATE) | enrolling by invitation | — | 1,000 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06929910 | Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.(GS_ZKM) | recruiting | — | 200 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT04384757 | Comparison of Open and Laparoscopic Distal Gastrectomy for T4a Gastric Cancer | active not recruiting | N/A | 240 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT05342350 | International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy(STOP-HCC) | terminated | — | 360 | Johns Hopkins UniversityOTHER | 2 | Jun 12, 2025 | clinicaltrials |
| NCT03800134 | A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer(AEGEAN) | active not recruiting | Phase 3 | 825 | AstraZenecaINDUSTRY | 28 | Jun 11, 2025 | clinicaltrials |
| NCT04427072 | Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation(GeoMETry-III) | terminated | Phase 3 | 22 | Novartis PharmaceuticalsINDUSTRY | 18 | May 16, 2025 | clinicaltrials |
| NCT05178303 | Composition for Treating Cirrhosis and Liver Cancer (SB-1121)(SB-1121) | completed | Phase 4 | 134 | Nguyen Thi Trieu, MDINDIV | 2 | May 16, 2025 | clinicaltrials |
| NCT06943703 | Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma | completed | — | 809 | National Children's Hospital, VietnamOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT05421650 | Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr | recruiting | N/A | 240 | CHA UniversityOTHER | 5 | Apr 9, 2025 | clinicaltrials |
| NCT03280030 | A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML | completed | Phase 2 | 67 | Novartis PharmaceuticalsINDUSTRY | 6 | Mar 20, 2025 | clinicaltrials |
| NCT06863038 | Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in Vietnam(Predict_LS_VN) | not yet recruiting | — | 572 | University of Medicine and Pharmacy at Ho Chi Minh CityOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT05227261 | Early Detection of Five Common Cancers Using the ctDNA Analysing Test(K-DETEK) | completed | — | 9,057 | Gene SolutionsINDUSTRY | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06776120 | Fecal Immunochemical Test in Diagnosing Colorectal Cancer Among Vietnamese Patients with Lower Gastrointestinal Symptoms | not yet recruiting | N/A | 1,575 | Luu Ngoc MaiOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06292988 | Predictive Factors for Medullary Thyroid Cancer Aggressiveness(MYELO) | completed | — | 500 | Aristotle University Of ThessalonikiOTHER | 24 | Jan 3, 2025 | clinicaltrials |
| NCT05344339 | Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric Cancer | recruiting | N/A | 320 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT06202105 | Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer(LOTA) | recruiting | N/A | 210 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT04078152 | Durvalumab Long-Term Safety and Efficacy Study(WAVE) | completed | Phase 4 | 163 | AstraZenecaINDUSTRY | 31 | Dec 20, 2024 | clinicaltrials |
| NCT03035032 | A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients | completed | Phase 4 | 107 | Astellas Pharma Singapore Pte. Ltd.INDUSTRY | 8 | Nov 26, 2024 | clinicaltrials |
| NCT06681636 | Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure(HPV9vxFSW) | not yet recruiting | Phase 2 | 300 | National Institute of Hygiene and Epidemiology, VietnamOTHER | 2 | Nov 8, 2024 | clinicaltrials |
| NCT03191786 | A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy(IPSOS) | completed | Phase 3 | 453 | Hoffmann-La RocheINDUSTRY | 24 | Oct 23, 2024 | clinicaltrials |
| NCT03447769 | Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A(Canopy-A) | terminated | Phase 3 | 1,382 | Novartis PharmaceuticalsINDUSTRY | 41 | Oct 9, 2024 | clinicaltrials |
| NCT03839823 | Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer(RIGHT Choice) | completed | Phase 2 | 222 | Novartis PharmaceuticalsINDUSTRY | 13 | Oct 9, 2024 | clinicaltrials |
| NCT06589388 | ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer | recruiting | — | 100 | Gene SolutionsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05099978 | Asian Multicenter Prospective Study of ctDNA Sequencing(A-TRAIN) | unknown | — | 506 | National Cancer Center, JapanOTHER_GOV | 8 | Sep 4, 2024 | clinicaltrials |
| NCT04385368 | Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)(MERMAID-1) | completed | Phase 3 | 89 | AstraZenecaINDUSTRY | 33 | Aug 30, 2024 | clinicaltrials |
| NCT02112656 | Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)(OPTIMA) | completed | Phase 3 | 554 | ImunonINDUSTRY | 14 | Aug 20, 2024 | clinicaltrials |
| NCT04642469 | Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.(MERMAID-2) | completed | Phase 3 | 30 | AstraZenecaINDUSTRY | 25 | Jun 25, 2024 | clinicaltrials |
| NCT06087354 | Low vs. Air Oxygen Concentration CAPA-IVM Culture of Cumulus-oocyte Complexes | completed | N/A | 20 | Mỹ Đức HospitalOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT05017207 | Clinically Relevant Pancreatic Fistula After Pancreaticoduodenectomy | completed | — | 183 | Vo Truong QuocOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04985071 | Complication of Pancreatic Fistula and Bleeding After Pancreaticoduodenectomy in Treatment Periampullary Cancer(PF) | completed | — | 183 | Vo Truong QuocOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT03125902 | A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)(IMpassion131) | completed | Phase 3 | 653 | Hoffmann-La RocheINDUSTRY | 24 | Mar 26, 2024 | clinicaltrials |
| NCT05217407 | Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia(MASTERKEY ASIA) | recruiting | — | 1,000 | National Cancer Center, JapanOTHER_GOV | 7 | Mar 22, 2024 | clinicaltrials |
| NCT04590521 | HPV Vaccine Immunity in High-risk Women | completed | Phase 4 | 63 | Murdoch Childrens Research InstituteOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT06174532 | Virtual Surgical Planning in Mandibular Segmental Resection | unknown | N/A | 30 | University of Medicine and Pharmacy at Ho Chi Minh CityOTHER | 1 | Dec 27, 2023 | clinicaltrials |
| NCT02125461 | A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer(PACIFIC) | completed | Phase 3 | 713 | AstraZenecaINDUSTRY | 26 | Oct 10, 2023 | clinicaltrials |
| NCT06042816 | Analgesic Efficacy of Free-opioid Anesthesia for Colorectal Surgery | completed | N/A | 49 | Vietnam Military Medical UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04742192 | Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer(EARLY-EGFR) | completed | — | 601 | AstraZenecaINDUSTRY | 15 | Aug 14, 2023 | clinicaltrials |
| NCT04547465 | 2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors | unknown | — | 300 | Gia Dinh People HospitalOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05493358 | Long-term Outcomes of Open Versus Laparoscopic Distal Gastrectomy for T4a Gastric Cancer | completed | — | 472 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05825664 | Underwater Versus Conventional Endoscopic Mucosal Resection in the Treatment of Non-pedunculated Colorectal Polyps | unknown | N/A | 228 | University of Medicine and Pharmacy at Ho Chi Minh CityOTHER | 1 | Apr 24, 2023 | clinicaltrials |
| NCT05262621 | Effects of Music Intervention Combined With Progressive Muscle Relaxation in Cancer Patients | completed | N/A | 84 | The Nethersole School of NursingOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05301010 | Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients | completed | Phase 3 | 128 | Nanogen Pharmaceutical Biotechnology Joint Stock CompanyINDUSTRY | 1 | Feb 27, 2023 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials